The purpose of this study is to look at the effects of RN624 on moderate to severe knee pain due to osteoarthritis. This study will look at the safety and pain relieving effects of RN624 compared to placebo over a 4 month period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
450
10 mcg/kg
25 mcg/kg
50 mcg/kg
Walking knee pain scores
Time frame: Day 112
Overall knee pain scores
Time frame: Day 112
Incidence of adverse events and serious adverse events
Time frame: Day 112
WOMAC
Time frame: Day 112
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
100 mcg/kg
200 mcg/kg
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Phoenix, Arizona, United States
Pfizer Investigational Site
Phoenix, Arizona, United States
Pfizer Investigational Site
Tucson, Arizona, United States
Pfizer Investigational Site
Anaheim, California, United States
Pfizer Investigational Site
Cypress, California, United States
Pfizer Investigational Site
National City, California, United States
Pfizer Investigational Site
Sacremento, California, United States
Pfizer Investigational Site
Stamford, Connecticut, United States
Pfizer Investigational Site
Waterbury, Connecticut, United States
...and 38 more locations